AlzeCure Pharma Balance Sheet Health
Financial Health criteria checks 6/6
AlzeCure Pharma has a total shareholder equity of SEK35.5M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK42.6M and SEK7.0M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
Interest coverage ratio | n/a |
Cash | SEK 39.19m |
Equity | SEK 35.52m |
Total liabilities | SEK 7.04m |
Total assets | SEK 42.56m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AC6's short term assets (SEK42.4M) exceed its short term liabilities (SEK7.0M).
Long Term Liabilities: AC6 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: AC6 is debt free.
Reducing Debt: AC6 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AC6 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: AC6 has sufficient cash runway for 1 years if free cash flow continues to grow at historical rates of 2.6% each year.